VONTOBEL FINANCIAL PRODUCTS LTD. | Market Closed - Swiss Exchange 11:20:00 2024-07-10 am EDT | ||
| 99.8 CHF | +0.10% |
|
| 3 months | +2.78% | ||
| 6 months | +6.40% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-07-10 | 99.8 | +0.10% |
Delayed Quote Swiss Exchange
Last update July 10, 2024 at 11:20 am EDT
More quotesStatic data
| Product type | Reverse Convertibles |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | 
Vontobel
|
| RMAVJV | |
| ISIN | CH1280438552 |
| Date issued | 2023-07-20 |
| Strike | 274.7 $ |
| Maturity | 2024-07-22 (9 Days) |
| Parity | 0.27 : 1 |
| Emission price | 100 CHF |
| Emission volume | N/A |
| Settlement | cash |
| Currency | CHF |
Technical Indicators
| Highest since issue | 100.5 CHF |
|---|---|
| Lowest since issue | 74.4 CHF |
| Spread | 10 CHF |
| Spread % | 1.00% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
230.1
USD
Average target price
281.3
USD
Spread / Average Target
+22.27%
- Stock Market
- Certificates
- RMAVJV Certificat
